Scimago Journal & Country Rank
menu
| Title | Type | SJR |  H index |
Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Cancer | journal | 26.837 Q1 | 505 | 105 | 304 | 10805 | 10951 | 163 | 31.23 | 102.90 |  |
| 2 | Journal of the National Cancer Institute | journal | 4.986 Q1 | 387 | 211 | 719 | 2601 | 4647 | 510 | 6.60 | 12.33 | |
| 3 | Oncogene | journal | 2.334 Q1 | 370 | 315 | 1443 | 17364 | 9801 | 1437 | 6.48 | 55.12 | |
| 4 | British Journal of Cancer | journal | 3.000 Q1 | 272 | 448 | 1331 | 22747 | 10155 | 1182 | 7.28 | 50.77 | |
| 5 | European Journal of Cancer | journal | 2.501 Q1 | 245 | 402 | 1811 | 14117 | 9171 | 1524 | 4.66 | 35.12 | |
| 6 | Carcinogenesis | journal | 1.074 Q2 | 223 | 80 | 444 | 3785 | 1640 | 430 | 3.28 | 47.31 | |
| 7 | Leukemia | journal | 3.662 Q1 | 219 | 333 | 1125 | 11784 | 8477 | 975 | 7.59 | 35.39 | |
| 8 | Molecular Cancer | journal | 8.222 Q1 | 196 | 190 | 525 | 23895 | 14728 | 449 | 23.31 | 125.76 | |
| 9 | Breast Cancer Research | journal | 2.578 Q1 | 175 | 147 | 340 | 7128 | 2515 | 334 | 5.80 | 48.49 | |
| 10 | Cell Death and Disease | journal | 2.447 Q1 | 164 | 828 | 3153 | 48403 | 26701 | 3125 | 7.57 | 58.46 | |
| 11 | Neuro-Oncology | journal | 6.348 Q1 | 163 | 229 | 779 | 6987 | 7925 | 489 | 11.64 | 30.51 | |
| 12 | BMC Cancer | journal | 1.087 Q2 | 160 | 1237 | 3866 | 50992 | 13894 | 3864 | 3.34 | 41.22 | |
| 13 | Endocrine-Related Cancer | journal | 1.331 Q2 | 146 | 108 | 282 | 6365 | 1135 | 275 | 4.11 | 58.94 | |
| 14 | Journal of Hematology and Oncology | journal | 7.522 Q1 | 144 | 115 | 531 | 11441 | 12065 | 413 | 20.83 | 99.49 | |
| 15 | Oral Oncology | journal | 1.257 Q2 | 137 | 252 | 1344 | 6958 | 3530 | 678 | 2.25 | 27.61 | |
| 16 | Journal of Experimental and Clinical Cancer Research | journal | 2.806 Q1 | 120 | 307 | 943 | 18917 | 9710 | 940 | 9.65 | 61.62 | |
| 17 | Journal for ImmunoTherapy of Cancer | journal | 3.728 Q1 | 117 | 445 | 1590 | 19408 | 14743 | 1571 | 8.71 | 43.61 | |
| 18 | Signal Transduction and Targeted Therapy | journal | 8.737 Q1 | 117 | 457 | 1105 | 58854 | 23888 | 665 | 20.66 | 128.78 | |
| 19 | Leukemia and Lymphoma | journal | 0.790 Q3 | 102 | 309 | 1482 | 9499 | 2278 | 916 | 1.50 | 30.74 | |
| 20 | Cancer Gene Therapy | journal | 1.457 Q2 | 99 | 165 | 367 | 9395 | 1780 | 354 | 4.96 | 56.94 | |
| 21 | International Journal of Hyperthermia | journal | 0.827 Q2 | 98 | 139 | 540 | 5768 | 1730 | 523 | 3.02 | 41.50 | |
| 22 | Leukemia Research | journal | 0.694 Q3 | 96 | 123 | 405 | 3859 | 707 | 281 | 1.61 | 31.37 | |
| 23 | Japanese Journal of Clinical Oncology | journal | 0.612 Q3 | 95 | 168 | 661 | 3943 | 1233 | 600 | 1.57 | 23.47 | |
| 24 | Journal of Oral Pathology and Medicine | journal | 0.716 Q3 | 95 | 126 | 378 | 3699 | 1144 | 365 | 3.22 | 29.36 | |
| 25 | Future Oncology | journal | 1.029 Q2 | 90 | 244 | 1139 | 8090 | 3137 | 1076 | 2.78 | 33.16 | |
| 26 | Cancer Medicine | journal | 1.174 Q2 | 84 | 1839 | 2107 | 79006 | 8378 | 2097 | 3.68 | 42.96 | |
| 27 | Cancer Cell International | journal | 1.257 Q2 | 80 | 320 | 1641 | 23550 | 8631 | 1639 | 5.23 | 73.59 | |
| 28 | Cancer Communications | journal | 4.950 Q1 | 79 | 108 | 289 | 4873 | 3552 | 176 | 12.39 | 45.12 | |
| 29 | Prostate Cancer and Prostatic Diseases | journal | 1.711 Q1 | 78 | 199 | 355 | 6017 | 1550 | 312 | 4.15 | 30.24 | |
| 30 | Epigenomics | journal | 0.751 Q3 | 77 | 100 | 420 | 6506 | 1140 | 390 | 2.27 | 65.06 | |
| 31 | Advances in Biological Regulation | journal | 1.114 Q2 | 69 | 39 | 111 | 2651 | 395 | 105 | 2.77 | 67.97 | |
| 32 | ESMO Open | journal | 2.498 Q1 | 60 | 208 | 742 | 8307 | 4147 | 647 | 5.86 | 39.94 | |
| 33 | Cell Death Discovery | journal | 1.668 Q1 | 58 | 457 | 985 | 28728 | 5917 | 963 | 5.74 | 62.86 | |
| 34 | Hematological Oncology | journal | 0.820 Q2 | 54 | 143 | 344 | 5325 | 778 | 271 | 2.29 | 37.24 | |
| 35 | ecancermedicalscience | journal | 0.515 Q3 | 47 | 149 | 517 | 4500 | 776 | 517 | 1.17 | 30.20 | |
| 36 | Infectious Agents and Cancer | journal | 0.424 Q4 | 47 | 78 | 200 | 4349 | 636 | 195 | 3.00 | 55.76 | |
| 37 | Experimental Hematology and Oncology | journal | 2.384 Q1 | 42 | 103 | 201 | 7008 | 1426 | 145 | 6.15 | 68.04 | |
| 38 | Molecular Therapy - Oncolytics | journal | 1.494 Q2 | 42 | 97 | 488 | 5554 | 2595 | 478 | 5.35 | 57.26 | |
| 39 | Molecular and Cellular Oncology | journal | 0.471 Q3 | 37 | 4 | 244 | 155 | 237 | 156 | 0.88 | 38.75 | |
| 40 | npj Precision Oncology | journal | 2.871 Q1 | 36 | 134 | 227 | 7435 | 1667 | 224 | 6.48 | 55.49 | |
| 41 | European Journal of Cancer, Supplement | journal | 0.759 Q3 | 29 | 0 | 14 | 0 | 31 | 13 | 0.33 | 0.00 | |
| 42 | Cancer Treatment and Research Communications | journal | 0.793 Q3 | 23 | 107 | 477 | 4244 | 1166 | 459 | 2.49 | 39.66 | |
| 43 | Molecular and Clinical Oncology | journal | 0.446 Q4 | 19 | 98 | 647 | 3543 | 845 | 646 | 1.31 | 36.15 | |
| 44 | Cancer Reports | journal | 0.571 Q3 | 18 | 233 | 424 | 10378 | 804 | 417 | 1.89 | 44.54 | |
| 45 | FASEB BioAdvances | journal | 0.764 Q3 | 18 | 40 | 210 | 1940 | 560 | 202 | 2.52 | 48.50 | |
| 46 | NAR Cancer | journal | 2.127 Q1 | 17 | 62 | 133 | 4757 | 556 | 132 | 3.40 | 76.73 | |
| 47 | Function | journal | 0.987 Q2 | 16 | 74 | 173 | 3180 | 401 | 136 | 2.18 | 42.97 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data